Welcome to LookChem.com Sign In|Join Free

CAS

  • or

37777-70-1

Post Buying Request

37777-70-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

37777-70-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 37777-70-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,7,7,7 and 7 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 37777-70:
(7*3)+(6*7)+(5*7)+(4*7)+(3*7)+(2*7)+(1*0)=161
161 % 10 = 1
So 37777-70-1 is a valid CAS Registry Number.

37777-70-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(2-chloro-5-nitrophenyl)acetic acid

1.2 Other means of identification

Product number -
Other names 2-chloro-5-nitro-benzeneacetic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:37777-70-1 SDS

37777-70-1Relevant articles and documents

Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases

-

Page/Page column 67; 68, (2013/06/27)

The invention relates to dihydronaphthyridines and related compounds; compositions comprising an effective amount of a dihydronaphthyridine or a related compound; and methods for treating or preventing proliferative diseases comprising the administration of an effective amount of a dihydronaphthyridine or a related compound.

RAF INHIBITORS

-

Page/Page column 21, (2011/10/31)

The present invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one. These compounds are inhibitors or kinases such as Raf, including compounds that show anti-proliferative activity, including against tumor cells, and are useful in the treatment of

QUINAZOLINE DERIVATIVES FOR USE AGAINST CANCER

-

Page/Page column 102, (2008/06/13)

The invention concerns quinazoline derivatives of Formula (I) or a pharmaceutically-acceptable salt, solvate or pro-drug thereof, wherein each of p, R1, q, R2, R3, R4, R5, Ring A, X1, R6, r and R7 has any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders or in the treatment of disease states associated with angiogenesis and/or vascular permeability.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 37777-70-1